Daxor Corporation (NASDAQ: DXR)
$8.2900
-0.0099 ( +3.63% ) 2.9K
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Market Data
Open
$8.2900
Previous close
$8.2999
Volume
2.9K
Market cap
$38.72M
Day range
$8.0650 - $8.1850
52 week range
$7.1900 - $10.0400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
nt-ncsr/a | Quarterly Reports | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
nt-ncsr/a | Quarterly Reports | 1 | Feb 29, 2024 |
nt-ncsr | Quarterly Reports | 1 | Feb 29, 2024 |
8-k | 8K-related | 14 | Jan 02, 2024 |
4 | Insider transactions | 1 | Dec 06, 2023 |